Clinical Trial Update: Long-Term Outcomes of Teplizumab in Routine Clinical Care

View source ↗

Summary

An ongoing clinical trial is evaluating long-term outcomes of teplizumab used in routine clinical care for individuals with Type 1 diabetes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• TZIELD (TEPLIZUMAB-MZWV)

Snippet

Sponsor: Sanofi | Conditions: Type 1 Diabetes | Status: RECRUITING